A Broad Impact for Global Oncology
JAMA Oncology, August 8, 2019. Co-authors from International Cancer Expert Corps
Emphasizing the critical importance of EXPERTISE, the article, “A Broad Impact for Global Oncology” available at the bottom of this post and online at https://jamanetwork.com/journals/jamaoncology/fullarticle/2747881, emphasizes the breadth of opportunities for global oncology. The critical need for mentorship is a driving force of ICEC with the creation of a career path being essential. The breadth of expertise required- noted on the ICEC website- creates an opportunity for many participants in all stages of their careers.
Figure 1 from the paper includes all that can be accomplished, requiring global partnerships, innovative thinking and built up Expertise.
The paper concludes: “The size and complexity of the problems present a grand challenge worthy of the best minds and transformational approaches, often requiring partnerships that have the potential for common projects even among countries and neighbors who have political conflicts. How could one not want to eradicate cancer and its deleterious impact? The Figure provides the components and benefits of a systems approach that supports leading-edge science and technology but, critically, pays attention to those populations historically and currently left behind in the trailing-edge turbulence of inequality. In this way, creativity, innovation, altruism, and commitment can bring rewarding results.”
The critical need for mentorship is a driving force of ICEC with the creation of a career path being essential. The breadth of expertise required- noted on the ICEC website- creates an opportunity for many participants in all stages of their careers.A Broad Impact for Global Oncology
Global oncology demands attention, with approximately 9 million people dying from cancer annually. It provides an extraordinary opportunity to address the urgent need for cancer care and be a catalyst for solutions to address critical societal issues including the disruptive forces in and among countries involving the health of individuals and the planet, relationships among cultures, the digital revolution, inequality, and the sociopolitical conflict of globalism vs isolationism. Read the article published online in JAMA Oncology
The alarming report released by the WHO details the staggering drain that disease has on the African economy. It projects that by 2030, the loss in GDP could be almost $1.7 trillion unless ambitious goals to increase the investment in health care improvement are met. The report also highlights the large percentage (37%) that non-communicable diseases account for in this burden. The necessary shift to translate political commitments into investment is possible by implementing changes not only to treat disease but to promote good health and prevention.
ICEC’s response to Richard Horton’s thoughtful commentary, “Offline: Why has global health forgotten cancer?” was published in The Lancet.
While prevention is critical, tackling cancer is about much more than just prevention. “The solution to the deficit of global cancer care is a systematic approach to build expertise, capacity, and capability using a sustainable model that recognizes the mutually beneficial links among cancer, the other non-communicable diseases, infectious diseases, and health-care systems, while also producing economic benefit”. Read more…
Motivated by stunning projections regarding the rise of cancer cases globally to 25 million cases in 2035 with 70% of those occurring in low- and middle- income countries, coupled with the paucity of access to radiotherapy treatment – an essential component of curative and palliative care – a group of individuals from the International Cancer Expert Corps (ICEC), Science and Technology Facilities Council (STFC UK), CERN and others, took on the challenge to meet the demands for cancer care focusing on the need to develop a medical linear accelerator to be used in resource-limited settings. Read the Editorial in Clinical Oncology
ICEC’s Senior Scientific Advisor, Dr. C. Norman Coleman, received the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care. The award recognizes exceptional providers who are transforming cancer care.
The Stovall Award is awarded annually to individuals, organizations, or other entities who demonstrate innovation in improving cancer care for patients in America. NCCS created the Stovall Award in honor of Ellen Stovall, NCCS’ longtime CEO who passed away in 2016 due to cardiac complications from her cancer treatment. Read more…